The clinical science behind the leading cause of Dry Eye, Meibomian Gland Dysfunction (MGD), and its treatment, is supported by over 25 years of scientific research. The gland blockages that occur because of MGD can be cleared most effectively by gently heating and massaging the inner and outer lid. This is known as thermal pulsation treatment and LipiFlow® is the only FDA cleared device that provides both inner and outer lid therapy.
LipiFlow is a treatment device specifically designed for effectively removing blockages from the meibmomian glands, allowing them to properly function and produce the oils that make up the top protective lipid layer of the tear film. Supported by 37 patents and used around the world by leading eye care professionals, LipiFlow is fast becoming the standard of care for MGD with studies demonstrating its safe and effective results. LipiFlow was designed to minimize patient discomfort during a 12 minute in-office treatment that most patients describe as a gently massaging of the eye lids.
LipiFlow activators are single-use sterile devices that safely and comfortably deliver automated therapeutic energies to the Meibomian glands, while protecting the delicate structures of the patient’s eye. The activators are specifically designed to be placed under and over the eye lids and are contoured above the cornea, so that the activators themselves avoid contact with the core eye surface. The placement of the activators on the eyes and treatment is a simple process that is done with minimal discomfort, on average.
Once the activators are placed on the eyes, treatment begins. The LipiFlow activator delivers a combination of heat and gentle pressure to the inner lids using what is called Vectored Thermal Pulse (VTP), with a simultaneous therapeutic motion on the outer lid. This unique combination of patented vectored heat and gentle adaptive pressure safely removes gland obstruction or old gland content. The entire treatment takes 12 minutes and, as normal gland function recovers, maximum results are usually experienced 6-8 weeks after treatment.
When LipiFlow treatment is properly applied, the glands can resume normal oil production or what is known as lipids. This oil is essential for a healthy tear film and for protecting the tear layer or watery layer of your eyes. When the water layer is exposed due to lack of oils on the top of the tear film due to Meibomian Gland Dysfunction (MGD) or gland blockages, the result is the leading cause of Dry Eye Symptoms.
Find an eye care professional near you who can evaluate your gland structure and function. If you have suffered from Dry Eye symptoms, it is highly likely you have MGD and the long-term effects can lead to permanent damage. Early detection is essential.
Your eye care professional will perform a series of diagnostic tests to evaluate gland performance and the health of your gland secretions. This will help to determine the root cause of Dry Eye Disease. You can assess your Dry Eye symptoms online and your doctor may have you complete a short questionnaire. A series of other simple test can be performed that may include compression of the lid under a slit lamp and using Dynamic Meibomian Imaging™ (DMI) that provides a high resolution picture of your gland structure. If you are experiencing Dry Eye symptoms, it is essential that you ask your eye doctor to check for Meibomian Gland Dysfunction (MGD). If you have MGD, LipiFlow may be an optimal treatment to ensure long-term eye health and to alleviate Dry Eye and MGD symptoms.
Copyright © Casey Optical Too 2019. All rights reserved.
All logos are trademarks of individual companies
Designed by Hexadesigns